RecruitingNot Applicable

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

United States100 participantsStarted 2025-09-02

Plain-language summary

To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Participants who are seen preoperatively at our institution before surgery for primary malignant bone tumor or primary malignant soft tissue tumor will be identified. * Adult orthopedic oncology patients. Stratified by diagnosis of primary malignant bone tumor and primary malignant soft tissue tumor. Exclusion Criteria • Non-English subjects will not be recruited. Subjects are required to be able to read/write in English.

What they're measuring

Questionnaires

Timeframe: Through study completion; an average of 1 year

Trial details

NCT IDNCT07215611

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-10-02

Contact for this trial

Shalin S Patel, MD

713-792-6268 sspatel@mdanderson.org

View on ClinicalTrials.gov More Bone Sarcomas trials